Abstract
Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
Bridget Griffiths, Sarah Miles, Hilary Moss, Rod Robertson, Douglas Veale and Paul Emery
The Journal of Rheumatology November 2002, 29 (11) 2371-2378;
Bridget Griffiths
Sarah Miles
Hilary Moss
Rod Robertson
Douglas Veale
In this issue
Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
Bridget Griffiths, Sarah Miles, Hilary Moss, Rod Robertson, Douglas Veale, Paul Emery
The Journal of Rheumatology Nov 2002, 29 (11) 2371-2378;
Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
Bridget Griffiths, Sarah Miles, Hilary Moss, Rod Robertson, Douglas Veale, Paul Emery
The Journal of Rheumatology Nov 2002, 29 (11) 2371-2378;